Evidence map›Paper›PMID 26269427›Full record

ArticleOpen biology2015

Cytokines and growth factors cross-link heparan sulfate.

Elisa Migliorini, Dhruv Thakar, Jens Kühnle, Rabia Sadir, Douglas P Dyer, Yong Li, Changye Sun, Brian F Volkman, Tracy M Handel, Liliane Coche-Guerente and 3 more

Open access · goldAbstract read
In one paragraph

Article in Open biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Frontiers in molecular biosciences · 2023
    Article
  11. Article
  12. Role of extracellular matrix proteoglycans in immune cell recruitment.International journal of experimental pathology · 2022
    Review
  13. Perspectives on the Biological Role of Chemokine:Glycosaminoglycan Interactions.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2021
    Review
  14. Heparanase and the hallmarks of cancer.Journal of translational medicine · 2020
    Review
  15. Review
  16. Review
  17. Pleiotrophin: Activity and mechanism.Advances in clinical chemistry · 2020
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 5 countries.

Elisa MiglioriniUniversité Grenoble Alpes, Departement de Chimie Moléculaire (DCM), Grenoble, France CNRS, DCM, Grenoble, France CIC biomaGUNE, San Sebastian, Spain.
Dhruv ThakarUniversité Grenoble Alpes, Departement de Chimie Moléculaire (DCM), Grenoble, France CNRS, DCM, Grenoble, France.
Jens KühnleDepartment of Biophysical Chemistry, University of Heidelberg, Heidelberg, Germany.
Rabia SadirUniversité Grenoble Alpes, Institut de Biologie Structurale (IBS), Grenoble, France CNRS, IBS, Grenoble, France CEA, IBS, Grenoble, France.
Douglas P DyerUniversity of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, CA, USA.
Yong LiDepartment of Biochemistry, Institute of Integrative Biology, University of Liverpool, Liverpool, UK.
Changye SunDepartment of Biochemistry, Institute of Integrative Biology, University of Liverpool, Liverpool, UK.
Brian F VolkmanDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, USA.
Tracy M HandelUniversity of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, CA, USA.
Liliane Coche-GuerenteUniversité Grenoble Alpes, Departement de Chimie Moléculaire (DCM), Grenoble, France CNRS, DCM, Grenoble, France.
David G FernigDepartment of Biochemistry, Institute of Integrative Biology, University of Liverpool, Liverpool, UK.
Hugues Lortat-JacobUniversité Grenoble Alpes, Institut de Biologie Structurale (IBS), Grenoble, France CNRS, IBS, Grenoble, France CEA, IBS, Grenoble, France.
Ralf P RichterUniversité Grenoble Alpes, Departement de Chimie Moléculaire (DCM), Grenoble, France CNRS, DCM, Grenoble, France CIC biomaGUNE, San Sebastian, Spain Max Planck Institute for Intelligent Systems, Stuttgart, Germany rrichter@cicbiomagune.es.ORCID http://orcid.org/0000-0003-3071-2837
Centre National de la Recherche Scientifique · FRUniversity of Liverpool · GBUniversity of California San Diego · USHeidelberg University · DEMedical College of Wisconsin · US

Funding

STRUCTURE OF MACROPHAGE CHEMOTACTIC ACTIVATING PROTEINSR01AI037113 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HANDEL, TRACY M · 1995 to 2015
$5.2M
Structural Basis for Chemokine FunctionR01AI058072 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI VOLKMAN, BRIAN F · 2004 to 2019
$4.1M
Structural Basis for Chemokine FunctionR37AI058072 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI Brian F Volkman · 2020 to 2026
$2.8M
NIAID NIH HHS R01 AI037113NIAID NIH HHS R01 AI058072NIAID NIH HHS R01AI058072NIAID NIH HHS R01AI37113NIAID NIH HHS R37 AI058072
6 · The paper itself

Abstract

The glycosaminoglycan heparan sulfate (HS), present at the surface of most cells and ubiquitous in extracellular matrix, binds many soluble extracellular signalling molecules such as chemokines and growth factors, and regulates their transport and effector functions. It is, however, unknown whether upon binding HS these proteins can affect the long-range structure of HS. To test this idea, we interrogated a supramolecular model system, in which HS chains grafted to streptavidin-functionalized oligoethylene glycol monolayers or supported lipid bilayers mimic the HS-rich pericellular or extracellular matrix, with the biophysical techniques quartz crystal microbalance (QCM-D) and fluorescence recovery after photobleaching (FRAP). We were able to control and characterize the supramolecular presentation of HS chains--their local density, orientation, conformation and lateral mobility--and their interaction with proteins. The chemokine CXCL12α (or SDF-1α) rigidified the HS film, and this effect was due to protein-mediated cross-linking of HS chains. Complementary measurements with CXCL12α mutants and the CXCL12γ isoform provided insight into the molecular mechanism underlying cross-linking. Fibroblast growth factor 2 (FGF-2), which has three HS binding sites, was also found to cross-link HS, but FGF-9, which has just one binding site, did not. Based on these data, we propose that the ability to cross-link HS is a generic feature of many cytokines and growth factors, which depends on the architecture of their HS binding sites. The ability to change matrix organization and physico-chemical properties (e.g. permeability and rigidification) implies that the functions of cytokines and growth factors may not simply be confined to the activation of cognate cellular receptors.

Indexed as

Chemokine CXCL12CytokinesExtracellular MatrixGlycosaminoglycansHeparan SulfateHumansIntercellular Signaling Peptides and ProteinsModels, MolecularMolecular ConformationProtein BindingChemokine CXCL12CytokinesGlycosaminoglycansHeparan SulfateIntercellular Signaling Peptides and Proteinschemokinecytokineextracellular matrixglycosaminoglcyangrowth factorheparan sulfate

Identifiers

PMID26269427
PMCPMC4554917
OpenAlexW2140163994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.